Scheel-Toellner D - Search Results

1

Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint.

Assi LK, Wong SH, Ludwig A, Raza K, Gordon C, Salmon M, Lord JM, Scheel-Toellner D. Assi LK, et al. Arthritis Rheum. 2007 Jun;56(6):1776-86. doi: 10.1002/art.22697. Arthritis Rheum. 2007. PMID: 17530706 Free PMC article.

2

Inhibition of T cell apoptosis in the rheumatoid synovium.

Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN. Salmon M, et al. J Clin Invest. 1997 Feb 1;99(3):439-46. doi: 10.1172/JCI119178. J Clin Invest. 1997. PMID: 9022077 Free PMC article.

3

RGD peptides induce apoptosis by direct caspase-3 activation.

Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM, Salmon M. Buckley CD, et al. Nature. 1999 Feb 11;397(6719):534-9. doi: 10.1038/17409. Nature. 1999. PMID: 10028971

4

Interferon-beta mediates stromal cell rescue of T cells from apoptosis.

Pilling D, Akbar AN, Girdlestone J, Orteu CH, Borthwick NJ, Amft N, Scheel-Toellner D, Buckley CD, Salmon M. Pilling D, et al. Eur J Immunol. 1999 Mar;29(3):1041-50. doi: 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#. Eur J Immunol. 1999. PMID: 10092109 Free article.

5

Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta.

Scheel-Toellner D, Pilling D, Akbar AN, Hardie D, Lombardi G, Salmon M, Lord JM. Scheel-Toellner D, et al. Eur J Immunol. 1999 Aug;29(8):2603-12. doi: 10.1002/(SICI)1521-4141(199908)29:08<2603::AID-IMMU2603>3.0.CO;2-L. Eur J Immunol. 1999. PMID: 10458775 Free article.

6

High cell density provides potent survival signals for resting T-cells.

Pilling D, Akbar AN, Shamsadeen N, Scheel-Toellner D, Buckley C, Salmon M. Pilling D, et al. Cell Mol Biol (Noisy-le-grand). 2000 Feb;46(1):163-74. Cell Mol Biol (Noisy-le-grand). 2000. PMID: 10726982

7

Serine/threonine protein kinases and apoptosis.

Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Cross TG, et al. Exp Cell Res. 2000 Apr 10;256(1):34-41. doi: 10.1006/excr.2000.4836. Exp Cell Res. 2000. PMID: 10739649 Review.

8

Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium.

Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord JM, Scheel-Toellner D, Salmon M. Buckley CD, et al. J Immunol. 2000 Sep 15;165(6):3423-9. doi: 10.4049/jimmunol.165.6.3423. J Immunol. 2000. PMID: 10975862

9

Type 1 IFN maintains the survival of anergic CD4+ T cells.

Lombardi G, Dunne PJ, Scheel-Toellner D, Sanyal T, Pilling D, Taams LS, Life P, Lord JM, Salmon M, Akbar AN. Lombardi G, et al. J Immunol. 2000 Oct 1;165(7):3782-9. doi: 10.4049/jimmunol.165.7.3782. J Immunol. 2000. PMID: 11034383

10

Regulation of neutrophil apoptosis: a role for protein kinase C and phosphatidylinositol-3-kinase.

Webb PR, Wang KQ, Scheel-Toellner D, Pongracz J, Salmon M, Lord JM. Webb PR, et al. Apoptosis. 2000 Nov;5(5):451-8. doi: 10.1023/a:1009601220552. Apoptosis. 2000. PMID: 11256888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page